Lyophilised vial, typically 5 mg or 10 mg
The potential molecular pathways that can be targeted include IL-4-IL-13-JAK-STAT-MAP kinases, adiponectin-iNOS-NF-B, PGD2-CRTH2, IFNs-RIG, Wnt/-catenin-FAM13A, FOXC1-miR-PI3K/AKT, JNK-Gal-7, Nrf2-ROS, Foxp3-RORt, CysLTR, AMP, Fas-FasL, PTHrP/PPAR, PAI-1, FcRI-LAT-SLP-76, Tim-3-Gal-9, TLRs-MyD88, PAR2, and Keap1/Nrf2/ARE
So each 250 mcg dose is 10 units on the syringe, and the vial holds twenty such doses
NAC: Proteccin de los vulos frente al estrs oxidativo La N-acetilcistena (NAC) es un precursor del glutatin, el antioxidante interno ms abundante del organismo
Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis
Tobacco related carcinogens undergo metabolic activation with the help of detoxifying enzymes and pathways promoting excretion [10]